Unlock instant, AI-driven research and patent intelligence for your innovation.

Middle ear mucosa-like cell sheet, process of producing the same and method of using the same

a cell sheet and middle ear technology, applied in the field of middle ear mucosa-like cell sheet, can solve the problems of largely losing the function of cilia, unable to preserve the mucosa in the mastoid antrum, and delay in the conversion of the mucosa to epithelium after surgery

Inactive Publication Date: 2013-10-31
TOKYO WOMENS MEDICAL UNIV +2
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a middle ear mucosa-like cell sheet that can be grafted onto the surface of the middle ear bone. This cell sheet helps prevent the growth of granulation tissue, bone, and fibroblasts within the middle ear cavity and acts as a replacement for the lost mucosa of the middle ear. It can also be used to treat nasal or oral cavity membrane loss.

Problems solved by technology

However, in many cases of cholesteatoma, it is difficult to preserve the mucosa in the mastoid antrum.
Further, it is known that under such a diseased state, conversion of the mucosa to epithelium after surgery is delayed and the function of gas exchange through the mucosa and the function of the cilia are largely lost.
In fact, although transplantation of nasal mucosa or oral mucosa, and use of collagen sponge have been studied, suturing in the narrow middle ear cavity is difficult, and it was found that the exposed bone surface is not appropriate as a scaffold of taking (see Non-patent documents 3 and 4).
Further, there are many unclear points about the effect thereof.
On the other hand, when we think about clinical application to human, some problems surface.
Further, there are some problems when a patient has advanced lesion, for example, tissue removal from a middle ear mucosa is difficult and it need preoperation to obtain the mucosa, in some cases, a mucosa from healthy tissue may be needed and ethical problem may also surface.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Middle ear mucosa-like cell sheet, process of producing the same and method of using the same
  • Middle ear mucosa-like cell sheet, process of producing the same and method of using the same
  • Middle ear mucosa-like cell sheet, process of producing the same and method of using the same

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0068]A tissue fragment of rabbit nasal mucosa. collected under the germfree condition was ex-planted onto a culture dish coated with type 1 collagen, and a primary culture was done with a KCM medium (Keratinocyte culture medium). Consequently, the nasal mucous epithelial cells crawled out of the surrounding area of the tissue fragment, and increased rapidly. Several days after the culture, the interfusion of the cells displaying the fibroblast cytoid form in part was observed. After culturing up to about 80% confluent, the nasal mucosa epithelial cells were recovered from the culture dish, and disseminated at a cell density of 5×104 cells / cm onto the temperature-responsive culture dish (poly (N-isopropylacrylamide), coat volume 2.0 μg / cm2) coated with collagen for tissue (CELLGEN). At that time, the temperature-responsive culture dish was obtained by applying 0.35 ml of N-isopropylacrylamide monomer dissolved in isopropyl alcohol at 35% onto the Falcon 3002 petri dish (6 cm diamete...

example 2

[0072]By the same method as Example 1, the section of inferior turbinate mucosa tissue in human nasal cavity (FIG. 12 upper left photograph) collected under the germfree condition was explanted on the culture dish coated with type I collagen, and a primary culture was done with KCM medium (Keratinocyte culture medium) (FIG. 12 lower left photograph). As illustrated in FIG. 10, the human nasal mucosa cell was disseminated on the cell insert whose porous membrane portion was coated with 1.5 μg / cm2 volume of poly (N-isopropylacrylamide) by the same method as Example 1, and the obtained nasal mucosa cell was cultivated with the culture surface touched to air. After the culture for six days, it was transferred to the CO2 incubator at 20° C., and recovered successfully as the human nasal mucosa cell sheet by performing low temperature treatment for 20 minutes (FIG. 12 lower right photograph). The process of operation is illustrated in FIG. 11. Also, the situation of each process was illus...

example 3

[0074]The portion of nasal mucosa epithelial tissue was detached from inferior turbinate mucosa tissue in human nasal cavity which was collected under the germfree condition, the nasal mucosa epithelial tissue was explanted on commercially-supplied culture dish, and the primary culture was done with KCM medium. The obtained nasal mucosa epithelial tissue is illustrated in FIG. 17, and the rest detached the nasal mucosa epithelial tissue is illustrated in FIG. 18. The human nasal mucosa cell was disseminated on the cell insert whose porous membrane portion was coated with 1.2 μg / cm2 volume of poly (N-isopropylacrylamide) by the same method as Example 1, and cultivated with the culture surface touched to air. At that time, the KCM medium containing human serum 10% was utilized as a medium. After the culture for seven days, it was transferred to the CO2 incubator at 20° C., and recovered successfully as the human nasal mucosa cell sheet by performing low temperature treatment for 20 mi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
critical dissolution temperatureaaaaaaaaaa
Login to View More

Abstract

The purpose of the present invention is to obtain an alternative to a substitute of the mucosa in the middle ear which is engrafted on the surface of the bone in the middle ear, hyperplasia of the granulation tissue and the bone and the development of the fibroblast cell sir the middle ear are suppressed, and to obtain a middle ear mucosa-like cell sheet retaining cilia in the surface layer, comprising culturing nasal epithelium cells on a cell culture substrate coated with a polymer whose hydration force changes within a temperature range of 0 to 80 ° C., wherein the cells are cultured within a temperature range where the hydration force of the polymer is weak, and then changing the temperature to a temperature at which the hydration force is strong to recover the cultured cell sheet.

Description

TECHNICAL FIELD[0001]The present invention relates to a middle ear mucosa-like cell sheet useful in the field of medicine, biology, drug discovery, pharmacology, etc., a method for producing the same, and a method of use thereof. The present application claims priority to a Japanese application (Japanese Patent Application No. 2010-226055) filed on Sep. 15, 2010.BACKGROUND ART[0002]In surgeries of middle otitis including cholesteatoma in the field of otolaryngology, in cases where the mucosa can be preserved, recovery of physiological functions of the mucosa can be expected, and pneumatic space is assured in the middle ear cavity or the mastoid antrum after surgery. However, in many cases of cholesteatoma, it is difficult to preserve the mucosa in the mastoid antrum. Especially, in cases where a large area of the bone surface is exposed, it is highly probable that the formed eardrum is concaved again due to the occlusion of the isthmus of tympanum or due to the postoperative change ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61F2/18
CPCA61F2/18A61F2002/183A61K35/12A61L2430/14C12N5/062C12N2533/30A61L27/3804A61F2310/00365A61P27/16A61L27/3813A61L27/3839A61L27/3886
Inventor HAMA, TAKANORIKOJIMA, HIROMIMORIYAMA, HIROSHIYAMATO, MASAYUKIOKANO, TERUO
Owner TOKYO WOMENS MEDICAL UNIV